These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8999189)

  • 1. [Retrovir in the treatment of acute viral hepatitis B].
    Rakhmanova AG; Demidenko TP; Maanaev TI
    Klin Med (Mosk); 1996; 74(5):53-5. PubMed ID: 8999189
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B escape mutant reactivation in a renal transplant patient.
    Le Pendeven C; Cuzon G; Fontaine H; Zatla F; Schneider V; Amiel C; Khayat R; Nicolas JC; Soussan P
    J Clin Virol; 2007 Sep; 40(1):74-6. PubMed ID: 17652016
    [No Abstract]   [Full Text] [Related]  

  • 3. Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). The CAESAR Coordinating Committee.
    Dore GJ; Cooper DA; Barrett C; Goh LE; Thakrar B; Atkins M
    J Infect Dis; 1999 Sep; 180(3):607-13. PubMed ID: 10438346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of hepatitis B].
    Telegdy L
    Orv Hetil; 2004 Nov; 145(45):2293-6. PubMed ID: 15573894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lamivudine treatment consensus from relative experts].
    Lamivudine Clinical Practice Group
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):157-8. PubMed ID: 12108391
    [No Abstract]   [Full Text] [Related]  

  • 6. Preventing infection-associated cancer: from bench to hillside.
    Goedert JJ
    J Natl Cancer Inst; 2005 Feb; 97(4):245-6. PubMed ID: 15713953
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis B reactivation in a hepatitis B surface antigen-negative patient after allogeneic bone marrow transplant: successful treatment with lamivudine and seroconversion.
    Pérez-Grande R; Gutiérrez-Zufiaurre N; Muñoz-Criado S; Blázquez de Castro AM; Vázquez López L; González San Martín F; García Rodríguez JA; Muñoz Bellido JL
    Diagn Microbiol Infect Dis; 2009 May; 64(1):80-2. PubMed ID: 19304434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic mice as a chemotherapeutic model for hepatitis B virus infection.
    Morrey JD; Korba BE; Sidwell RW
    Antivir Ther; 1998; 3(Suppl 3):59-68. PubMed ID: 10726056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.
    Knöll A; Boehm S; Hahn J; Holler E; Jilg W
    J Viral Hepat; 2007 Jul; 14(7):478-83. PubMed ID: 17576389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology, clinical efficacy and safety of lamivudine in hepatitis B virus infection.
    Kumar M; Sarin SK
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):465-95. PubMed ID: 19072396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome of renal transplantation in patients with positive pre-transplant hepatitis B surface antigen.
    Ahn HJ; Kim MS; Kim YS; Kim SI; Huh KH; Ju MK; Ahn SH; Han KH
    J Med Virol; 2007 Nov; 79(11):1655-63. PubMed ID: 17854044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan.
    Suzuki Y; Kobayashi M; Ikeda K; Suzuki F; Arfase Y; Akuta N; Hosaka T; Saitoh S; Kobayashi M; Someya T; Matsuda M; Sato J; Watabiki S; Miyakawa Y; Kumada H
    J Med Virol; 2005 May; 76(1):33-9. PubMed ID: 15779048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of hepatitis B virus infection with Lamivudine after heart transplantation.
    Wang SS; Chou NK; Chi NH; Hsu RB; Huang SC; Chen YS; Yu HY; Tsao CI; Ko WJ; Lai MY; Chu SH
    Transplant Proc; 2006 Sep; 38(7):2138-40. PubMed ID: 16980024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sylimarol in the treatment of acute viral hepatitis].
    Tkacz B; Dworniak D
    Wiad Lek; 1983 Apr; 36(8):613-6. PubMed ID: 6353775
    [No Abstract]   [Full Text] [Related]  

  • 15. The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.
    Gwak GY; Huh W; Lee DH; Choi MS; Lee JH; Koh KC; Kim SJ; Joh JW; Oh HY
    Transplant Proc; 2007 Dec; 39(10):3121-6. PubMed ID: 18089336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy.
    Filippini P; Coppola N; Pisapia R; Scolastico C; Marrocco C; Zaccariello A; Nacca C; Sagnelli C; De Stefano G; Ferraro T; De Stefano C; Sagnelli E
    AIDS; 2006 Jun; 20(9):1253-60. PubMed ID: 16816553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients.
    Benhamou Y; Fleury H; Trimoulet P; Pellegrin I; Urbinelli R; Katlama C; Rozenbaum W; Le Teuff G; Trylesinski A; Piketty C;
    Hepatology; 2006 Mar; 43(3):548-55. PubMed ID: 16496322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New domestic phospholipid preparation "Fosfogliv" as an effective treatment for patients with acute viral hepatitis].
    Uchaĭkin VF; Luchshev VI; Zharov SN; Kovalev OB; Ipatova OM; Tikhonova EG; Torkhovskaia TI; Kniazhev VA; Dunaevskiĭ OA; Archakov AI
    Klin Med (Mosk); 2000; 78(5):39-42. PubMed ID: 10881509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Should chronic active viral hepatitis be treated with drugs or not?].
    Schalm SW
    Internist (Berl); 1981 Dec; 22(12):717-20. PubMed ID: 7033161
    [No Abstract]   [Full Text] [Related]  

  • 20. Lamivudine therapy for hepatitis B infection in post-renal transplant patients: results after 36 months follow-up.
    de Silva HJ; Herath CA; Sheriff MH
    Liver Int; 2005 Oct; 25(5):1074-5. PubMed ID: 16162169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.